Family Medicine · Hot Springs, AR
NPI
1922101716
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
1629 Airport Rd, Suiteb
Hot Springs, AR, 71913
Phone (501) 767-0075
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
44,312 services
Medicare patients, 2024
643
Average age 74
Drug cost, 2024
$1.0M
13,451 prescriptions
Company payments, 2025
$786
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin D Hale was code J1071 (injection, testosterone cypionate, 1 mg), 35,550 times for 15 patients. In total Kevin D Hale billed 44,312 services in 215 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 35,550 | 15 | $0.02 | $633 |
| 99214 Office E&M - Established | Office | 1,050 | 387 | $41.29 | $43K |
| 85025 Blood Count | Office | 882 | 372 | $7.52 | $6,628 |
| 80053 Clinical Chemistry | Office | 878 | 369 | $10.24 | $8,987 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 785 | 78 | $0.69 | $539 |
| 80061 Clinical Chemistry | Office | 443 | 314 | $12.97 | $5,744 |
| 84443 Clinical Chemistry | Office | 313 | 193 | $16.46 | $5,152 |
| 84481 Clinical Chemistry | Office | 311 | 190 | $16.55 | $5,146 |
| 84439 Clinical Chemistry | Office | 311 | 191 | $8.80 | $2,738 |
| 83036 Blood Count | Office | 273 | 117 | $9.44 | $2,577 |
| 96372 Injection Administration | Office | 254 | 55 | $8.60 | $2,184 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 196 | 41 | $0.08 | $15.22 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 184 | 37 | $0.31 | $56.4 |
| 17003 Destruction Skin Lesion | Office | 148 | 74 | $4.12 | $609 |
| 36415 Venipuncture Blood Collection | Office | 136 | 97 | $8.65 | $1,176 |
By year: 2022 $258K for 51,077 services; 2023 $232K for 46,179 services; 2024 $174K for 44,312 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 882 | 372 | $7.52 | $6,628 |
| 80053 Clinical Chemistry | 878 | 369 | $10.24 | $8,987 |
| 80061 Clinical Chemistry | 443 | 314 | $12.97 | $5,744 |
| 84443 Clinical Chemistry | 313 | 193 | $16.46 | $5,152 |
| 84439 Clinical Chemistry | 311 | 191 | $8.80 | $2,738 |
| 84481 Clinical Chemistry | 311 | 190 | $16.55 | $5,146 |
| 83036 Blood Count | 273 | 117 | $9.44 | $2,577 |
| 36415 Venipuncture Blood Collection | 136 | 97 | $8.65 | $1,176 |
| 82306 Clinical Chemistry | 123 | 114 | $28.60 | $3,518 |
| 81003 Clinical Chemistry | 106 | 76 | $2.14 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin D Hale prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 604 prescriptions and refills. In total Kevin D Hale wrote 13,451 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 604 | 604 | 111 | $14K |
| Levothyroxine Sodium Generic | 493 | 1,119 | 118 | $4,094 |
| Rosuvastatin Calcium Generic | 448 | 1,153 | 137 | $5,507 |
| Omeprazole Generic | 325 | 767 | 81 | $4,082 |
| Atorvastatin Calcium Generic | 295 | 672 | 75 | $2,303 |
| Pantoprazole Sodium Generic | 292 | 664 | 89 | $3,252 |
| Clonazepam Generic | 287 | 293 | 50 | $2,561 |
| Amlodipine Besylate Generic | 278 | 743 | 83 | $1,473 |
| Gabapentin Generic | 258 | 427 | 59 | $2,946 |
| Losartan Potassium Generic | 217 | 511 | 60 | $2,227 |
| Tramadol Hcl Generic | 205 | 205 | 37 | $1,107 |
| Tamsulosin Hcl Generic | 197 | 475 | 53 | $2,519 |
| Potassium Chloride Generic | 184 | 337 | 46 | $2,026 |
| Alprazolam Generic | 184 | 188 | 32 | $1,070 |
| Allopurinol Generic | 178 | 430 | 47 | $1,241 |
Brand drugs: 1,581 claims; generic drugs: 11,796 claims; opioid claims: 964.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin D Hale $786 ($786 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $257.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $257 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $112 |
| Pfizer Inc. PFE | 5 | $91.78 |
| Amgen Inc. AMGN | 5 | $74.03 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $70.79 |
| Abbott Laboratories ABT | 2 | $42.33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $21.58 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $21.43 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $18.82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $17.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.